Comparison of Anticancer Medication Use and Spending Under US Oncology Parity Laws With and Without Out-of-Pocket Spending Caps

IMPORTANCE: By 2020, nearly all states had adopted oncology parity laws in the US, ensuring that patients in fully insured private health plans pay no more for orally administered anticancer medications (OAMs) than infused therapies. Between 2013 and mid-2017, 11 states implemented parity with out-o...

Descripción completa

Detalles Bibliográficos
Autores principales: Dusetzina, Stacie B., Huskamp, Haiden A., Jazowski, Shelley A., Winn, Aaron N., Basch, Ethan, Keating, Nancy L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796987/
https://www.ncbi.nlm.nih.gov/pubmed/35977314
http://dx.doi.org/10.1001/jamahealthforum.2021.0673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796987/
https://www.ncbi.nlm.nih.gov/pubmed/35977314
http://dx.doi.org/10.1001/jamahealthforum.2021.0673

Ejemplares similares